Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006292 220002436 1.5 55 Curative (C) 2014-11-15 2014-11-15 FLAG + Idarubicin null N 220030003 FLAG + IDARUBICIN
220006293 220002436 null 80 Curative (C) null 2017-06-08 AML 19 TRIAL Y N 220030003 AML19 TRIAL
220006294 220002437 1.67 109.9 Curative (C) 2015-05-01 2015-05-01 FLAG + Idarubicin null null 220030010 FLAG + IDARUBICIN
220006295 220002437 null null Curative (C) 2015-06-17 2015-07-02 null null N 220030010 NOT MATCHED
220006296 220002437 null 65.8 Curative (C) 2014-08-29 2014-09-02 FLAG + Idarubicin 02 N 220030010 FLAG + IDARUBICIN
220006297 220002437 0 null null 2016-11-20 2017-02-09 Nilotinib N N 220030010 NILOTINIB
220006298 220002437 1.7 91.4 Curative (C) null 2015-05-10 AML 19 TRIAL 1 N 220030010 AML19 TRIAL
220006299 220002437 1.59 77 Palliative (P) 2017-11-04 2017-11-04 null N N 220030010 NOT MATCHED
220006300 220002438 null null Palliative (P) null 2017-02-03 Nilotinib N N 220030022 NILOTINIB
220006301 220002438 null null Palliative (P) 2015-02-26 2015-02-26 null null N 220030022 NOT MATCHED
220006302 220002438 1.77 78.9 Curative (C) null 2015-05-02 AML 19 TRIAL Y N 220030022 AML19 TRIAL
220006303 220002439 0 85 Curative (C) 2015-11-21 2015-11-22 DAUNORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE Y N 220030028 NOT MATCHED
220006304 220011382 null 0 Adjuvant (A) null 2015-11-19 Nilotinib N N 220030030 NILOTINIB
220006305 220002440 1.15 38.1 Palliative (P) 2015-04-10 2015-04-11 AML 19 TRIAL + CYTARABINE + FLUDARABINE + IDARUBICIN + mylotarg N N 220030035 NOT MATCHED
220006306 220002440 1.67 82.2 Curative (C) 2013-04-08 2013-04-12 FLAG + Idarubicin 02 N 220030035 FLAG + IDARUBICIN
220006307 220002441 0 null Disease modification (D) null 2013-04-12 Nilotinib 2 N 220030037 NILOTINIB
220006308 220002442 1.88 76.7 Curative (C) 2014-05-27 2014-05-27 AML 19 TRIAL 01 N 220030038 AML19 TRIAL
220006309 220002442 0 148.5 Adjuvant (A) 2016-02-13 2016-02-16 Nilotinib 02 N 220030038 NILOTINIB
220006310 220002443 null 97.5 Disease modification (D) 2018-04-02 2018-08-03 Nilotinib N N 220030042 NILOTINIB
220006311 220002444 1.76 71.4 Curative (C) 2017-10-18 2017-10-21 AML 19 TRIAL N N 220030046 AML19 TRIAL
220006312 220002445 null 98 Curative (C) 2015-12-09 2016-12-18 Nilotinib 02 N 220030047 NILOTINIB
220006313 220002445 1.59 54.5 Curative (C) 2014-11-28 2014-12-01 AML 19 TRIAL Y N 220030047 AML19 TRIAL
220006314 220002445 null 19.9 Curative (C) 2014-08-24 2014-08-24 null 1 Y 220030047 NOT MATCHED
220006315 220002446 1.68 68.6 Curative (C) 2017-02-16 2017-02-16 AML 19 TRIAL 01 N 220030052 AML19 TRIAL
220006316 220002446 1.76 null Curative (C) 2016-10-03 2016-10-06 FLAG + Idarubicin 99 N 220030052 FLAG + IDARUBICIN
220006317 220002446 1.94 101.8 Curative (C) 2014-11-16 2014-11-16 FLAG + Idarubicin 01 N 220030052 FLAG + IDARUBICIN
220006318 220002447 1.78 84.6 Curative (C) 2013-08-07 2013-08-07 FLAG + Idarubicin N N 220030058 FLAG + IDARUBICIN
220006319 220002447 0 78 Curative (C) 2013-11-01 2013-11-01 Nilotinib N N 220030058 NILOTINIB
220006320 220016123 0 0 Not known (9) 2013-09-26 2014-01-16 Nilotinib 2 N 220030065 NILOTINIB
220006321 220016123 1.66 66.6 Curative (C) 2017-07-18 2017-07-19 AML 19 TRIAL Y N 220030065 AML19 TRIAL
220006322 220016123 1.79 62.9 Curative (C) 2014-12-17 2014-12-23 AML 19 TRIAL Y N 220030065 AML19 TRIAL
220006323 220002448 1.73 102.6 Curative (C) 2015-08-25 2015-08-26 AML 19 TRIAL 01 N 220030072 AML19 TRIAL
220006324 220002448 1.72 0 Palliative (P) 2016-10-02 2016-10-02 AML MyeChild Y N 220030072 NOT MATCHED
220006325 220016124 1.5 101 Curative (C) 2016-07-06 2016-07-06 FLAG + Idarubicin N N 220030075 FLAG + IDARUBICIN
220006326 220016124 null null Disease modification (D) 2015-12-30 2015-12-30 Nilotinib N N 220030075 NILOTINIB
220006327 220016124 0.91 56 Curative (C) 2016-09-14 2016-09-14 null N N 220030075 NOT MATCHED
220006328 220016124 1.68 78 Adjuvant (A) 2015-04-23 2015-04-23 AML 19 TRIAL 2 N 220030075 AML19 TRIAL
220006329 220002449 1.79 62 Curative (C) 2017-06-12 2017-06-12 FLAG + Idarubicin N N 220030087 FLAG + IDARUBICIN
220006330 220002449 1.57 78.5 Curative (C) 2017-03-15 2017-03-15 AML 19 TRIAL Y N 220030087 AML19 TRIAL
220006331 220002449 1.63 77 Disease modification (D) 2016-12-27 2017-01-03 AML 19 TRIAL 1 N 220030087 AML19 TRIAL
220006332 220002450 1.66 78.3 Curative (C) 2015-12-14 2015-12-15 FLAG + Idarubicin 02 N 220030093 FLAG + IDARUBICIN
220006333 220002450 1.5 68.6 Curative (C) 2016-05-11 2016-05-17 FLAG + Idarubicin 2 N 220030093 FLAG + IDARUBICIN
220006334 220002450 null 93.8 Curative (C) 2013-04-12 2013-04-12 FLAG + Idarubicin N N 220030093 FLAG + IDARUBICIN
220006335 220002451 0 null Curative (C) 2017-06-24 2017-07-17 Nilotinib N N 220030106 NILOTINIB
220006336 220002451 1.88 null Curative (C) 2014-01-23 2014-01-25 AML 19 TRIAL 01 N 220030106 AML19 TRIAL
220006337 220002452 1.8 66.5 Curative (C) 2015-04-20 2015-05-01 AML 19 TRIAL Y N 220030110 AML19 TRIAL
220006338 220002452 1.66 85.5 Curative (C) 2015-05-28 2015-05-29 AML 19 TRIAL Y N 220030110 AML19 TRIAL
220006339 220002452 null null Disease modification (D) 2017-03-13 2017-03-13 Nilotinib 02 null 220030110 NILOTINIB
220006340 220002452 1.59 68.4 Curative (C) 2015-07-01 2015-07-11 AML 19 TRIAL 1 N 220030110 AML19 TRIAL
220006341 220002452 0 0 Unknown (U) 2016-06-30 2016-06-30 Nilotinib N N 220030110 NILOTINIB